Asia Pacific Nootropics Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Form (Capsules/Tablets, Powder, Drinks, and Others), By Country, Historical Data and Growth Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Nootropics Market
Market Report Description
The Asia Pacific Nootropics Market would witness market growth of 16.9% CAGR during the forecast period (2021-2027).
Natural nootropics that have been commercialized react through various methods, thereby impacting different parameters. The release of dopamine, phosphatidylinositol turnover, choline absorption, function of the -amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor, cholinergic transmission, and phosphatase A2 activity have all been reported to be stimulated by natural nootropics.
There are some nootropics that act like acetylcholine or glutamate receptor positive allosteric modulators. Additionally, they boost the long-term potential (LTP) and improve synaptic transmission by increasing neurotransmitter release and activity.
In India, the cases of mental illness have surged to a greater extend since it is among the worst hit countries by the COVID-19 pandemic. Many supplements that help in enhancing the brain health are witnessing a huge popularity in the developing nations of the region like China and India. According to NCBI, Indian people have recorded the horrifying impacts on the mental health during initial phase of the pandemic. With the growing awareness among consumers regarding the brain and mental wellness, the demand for various products helping in improving mental health has recorded a surge.
The China market dominated the Asia Pacific Nootropics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1.8 billion by 2027. The Japan market is experiencing a CAGR of 16.2% during (2021 - 2027). Additionally, The India market would register a CAGR of 17.6% during (2021 - 2027).
Based on Distribution Channel, the market is segmented into Offline and Online. Based on Form, the market is segmented into Capsules/Tablets, Powder, Drinks, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Nootropics Market is Projected to reach USD 24.6 Billion by 2027, at a CAGR of 14.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Mental Mojo, LLC, Onnit Labs, Inc., Peak Nootropics (Advanced Nootropics), Reckitt Benckiser Group PLC, Mind Lab Pro (Opti-Nutra, ltd.), Zhou Nutrition LLC (Nutraceutical International Corporation)TruBrain, Wolfson Holdco Limited (NooCube), NEU MIND, LLC, and Kraken Koffee, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Offline and
- Online
By Form
- Capsules/Tablets
- Powder
- Drinks, and
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Mental Mojo, LLC
- Onnit Labs, Inc.
- Peak Nootropics (Advanced Nootropics)
- Reckitt Benckiser Group PLC
- Mind Lab Pro (Opti-Nutra, ltd.)
- Zhou Nutrition LLC (Nutraceutical International Corporation)TruBrain
- Wolfson Holdco Limited (NooCube)
- NEU MIND, LLC
- Kraken Koffee, LLC
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Related Reports:
Global Nootropics Market Report 2021-2027
North America Nootropics Market Report 2021-2027